Vanguard Group’s Axogen AXGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$93.9M Buy
2,869,955
+190,557
+7% +$4.69M ﹤0.01% 1899
2025
Q3
$47.8M Sell
2,679,398
-51,003
-2% -$740K ﹤0.01% 2178
2025
Q2
$29.6M Buy
2,730,401
+191,794
+8% +$2.51M ﹤0.01% 2370
2025
Q1
$47M Buy
2,538,607
+112,679
+5% +$2.03M ﹤0.01% 2113
2024
Q4
$40M Buy
2,425,928
+139
+0% +$1.97K ﹤0.01% 2261
2024
Q3
$34M Buy
2,425,789
+13,873
+0.6% +$153K ﹤0.01% 2346
2024
Q2
$17.5M Buy
2,411,916
+513
+0% +$3.51K ﹤0.01% 2640
2024
Q1
$19.5M Sell
2,411,403
-54,093
-2% -$484K ﹤0.01% 2614
2023
Q4
$16.8M Sell
2,465,496
-13,025
-0.5% -$72.4K ﹤0.01% 2674
2023
Q3
$12.4M Buy
2,478,521
+56,536
+2% +$392K ﹤0.01% 2758
2023
Q2
$22.1M Buy
2,421,985
+67,343
+3% +$628K ﹤0.01% 2547
2023
Q1
$22.3M Buy
2,354,642
+401,473
+21% +$3.67M ﹤0.01% 2546
2022
Q4
$19.5M Buy
1,953,169
+47,126
+2% +$523K ﹤0.01% 2639
2022
Q3
$22.7M Buy
1,906,043
+15,749
+0.8% +$158K ﹤0.01% 2574
2022
Q2
$15.5M Sell
1,890,294
-32,671
-2% -$279K ﹤0.01% 2773
2022
Q1
$15.3M Buy
1,922,965
+38,968
+2% +$337K ﹤0.01% 2926
2021
Q4
$17.7M Buy
1,883,997
+23,792
+1% +$285K ﹤0.01% 2910
2021
Q3
$29.4M Buy
1,860,205
+76,573
+4% +$1.38M ﹤0.01% 2651
2021
Q2
$38.5M Sell
1,783,632
-150,927
-8% -$3.05M ﹤0.01% 2507
2021
Q1
$39.2M Buy
1,934,559
+41,760
+2% +$825K ﹤0.01% 2442
2020
Q4
$33.9M Buy
1,892,799
+43,920
+2% +$645K ﹤0.01% 2390
2020
Q3
$21.5M Sell
1,848,879
-59,590
-3% -$692K ﹤0.01% 2419
2020
Q2
$17.6M Buy
1,908,469
+26,162
+1% +$234K ﹤0.01% 2479
2020
Q1
$19.6M Buy
1,882,307
+7,377
+0.4% +$93.9K ﹤0.01% 2292
2019
Q4
$33.5M Buy
1,874,930
+20,882
+1% +$309K ﹤0.01% 2292
2019
Q3
$23.1M Buy
1,854,048
+85,476
+5% +$1.41M ﹤0.01% 2417
2019
Q2
$35M Buy
1,768,572
+93,873
+6% +$2.01M ﹤0.01% 2279
2019
Q1
$35.3M Buy
1,674,699
+30,206
+2% +$552K ﹤0.01% 2259
2018
Q4
$33.6M Buy
1,644,493
+59,374
+4% +$1.86M ﹤0.01% 2220
2018
Q3
$58.4M Buy
1,585,119
+74,226
+5% +$3.24M ﹤0.01% 2072
2018
Q2
$75.9M Buy
1,510,893
+163,468
+12% +$7.2M ﹤0.01% 1911
2018
Q1
$49.2M Buy
1,347,425
+18,010
+1% +$552K ﹤0.01% 2078
2017
Q4
$37.6M Buy
1,329,415
+63,400
+5% +$1.5M ﹤0.01% 2205
2017
Q3
$24.5M Buy
1,266,015
+42,946
+4% +$722K ﹤0.01% 2391
2017
Q2
$20.5M Buy
1,223,069
+101,245
+9% +$1.37M ﹤0.01% 2449
2017
Q1
$11.7M Buy
1,121,824
+35,076
+3% +$358K ﹤0.01% 2689
2016
Q4
$9.78M Buy
1,086,748
+92,604
+9% +$798K ﹤0.01% 2761
2016
Q3
$8.98M Buy
994,144
+218,696
+28% +$1.78M ﹤0.01% 2739
2016
Q2
$5.33M Buy
775,448
+295,294
+61% +$1.67M ﹤0.01% 2953
2016
Q1
$2.57M Buy
480,154
+65,509
+16% +$333K ﹤0.01% 3281
2015
Q4
$2.07M Buy
414,645
+60,482
+17% +$299K ﹤0.01% 3384
2015
Q3
$1.46M Buy
354,163
+71,461
+25% +$286K ﹤0.01% 3505
2015
Q2
$887K Buy
282,702
+4,405
+2% +$14.2K ﹤0.01% 3692
2015
Q1
$974K Buy
278,297
+112,790
+68% +$388K ﹤0.01% 3639
2014
Q4
$594K Buy
165,507
+2,600
+2% +$7.61K ﹤0.01% 3677
2014
Q3
$397K Buy
162,907
+17,259
+12% +$42.1K ﹤0.01% 3779
2014
Q2
$405K Buy
145,648
+1,600
+1% +$4.36K ﹤0.01% 3731
2014
Q1
$439K Buy
144,048
+50,080
+53% +$200K ﹤0.01% 3681
2013
Q4
$422K Buy
93,968
+81,568
+658% +$332K ﹤0.01% 3632
2013
Q3
$55K Buy
+12,400
New +$45.5K ﹤0.01% 3802

Other funds holding AXGN

Vanguard Group's AXGN Position: Q4 2025 in Review

Vanguard Group increased its Axogen (AXGN) stake by 7.1% in Q4 2025, buying an estimated $4.69M and bringing the position to 2,869,955 shares worth $93.9M. The position accounts for ﹤0.01% of the portfolio, ranked #1899.

Vanguard Group first reported a position in AXGN in Q3 2013 and has held it in 50 quarters since. 208 funds tracked by Wall St. Rank hold AXGN as of Q4 2025.

  • Vanguard Group held 2,869,955 shares of Axogen worth $93.9M as of Q4 2025.
  • Vanguard Group bought 190,557 Axogen shares in Q4 2025, an estimated $4.69M.
  • Axogen made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #1899 holding.
  • Vanguard Group first reported a position in Axogen in Q3 2013 and has held it in 50 quarters since.
  • 208 funds tracked by Wall St. Rank held Axogen as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.